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Elevated intracellular cAMP exacerbates
vulnerability to oxidative stress in optic
nerve head astrocytes
Myoung Sup Shim1, Keun-Young Kim2, Jung Hyun Bu1, Hye Seung Nam1, Seung Won Jeong1, Tae Lim Park1,
Mark H. Ellisman2, Robert N. Weinreb1 and Won-Kyu Ju1
Abstract
Glaucoma is characterized by a progressive loss of retinal ganglion cells and their axons, but the underlying biological
basis for the accompanying neurodegeneration is not known. Accumulating evidence indicates that structural and
functional abnormalities of astrocytes within the optic nerve head (ONH) have a role. However, whether the activation
of cyclic adenosine 3′,5′-monophosphate (cAMP) signaling pathway is associated with astrocyte dysfunction in the
ONH remains unknown. We report here that the cAMP/protein kinase A (PKA) pathway is critical to ONH astrocyte
dysfunction, leading to caspase-3 activation and cell death via the AKT/Bim/Bax signaling pathway. Furthermore,
elevated intracellular cAMP exacerbates vulnerability to oxidative stress in ONH astrocytes, and this may contribute to
axonal damage in glaucomatous neurodegeneration. Inhibition of intracellular cAMP/PKA signaling activation protects
ONH astrocytes by increasing AKT phosphorylation against oxidative stress. These results strongly indicate that
activation of cAMP/PKA pathway has an important role in astrocyte dysfunction, and suggest that modulating cAMP/
PKA pathway has therapeutic potential for glaucomatous ONH degeneration.
Introduction
Primary open-angle glaucoma (POAG) is characterized
by a slow and progressive degeneration of retinal ganglion
cells (RGCs) and their axons in the optic nerve (ON),
leading to loss of visual function1. The factors con-
tributing to axon degeneration in the optic nerve head
(ONH) in POAG are not well understood. Accumulating
evidence indicates that astrocyte dysfunction accom-
panied by RGC axon loss is closely associated with the
pathogenesis of glaucomatous ONH degeneration2–4.
Indeed, structural and functional abnormalities of astro-
cytes have been reported in the ONH of experimental
glaucoma models as well as patients with POAG2,3,5,6.
The ubiquitous second messenger cyclic adenosine 3′,5′-
monophosphate (cAMP) in the central nervous system
contributes to numerous biological processes including cell
growth and death7–10. Upon stimulation, cAMP synthesis
and its degradation are tightly regulated by adenyl cyclases
(ACs) and cyclic nucleotide phosphodiesterases (PDEs),
respectively8. Previous studies have demonstrated that the
basal level of cAMP was significantly higher in the unsti-
mulated glaucomatous ONH astrocytes from Caucasian
American and African American (AA) donors with POAG
compared with their unstimulated ONH astrocytes from
normal healthy counterparts11. Furthermore, elevated
hydrostatic pressure, a mimetic of high intraocular pressure
(IOP) in vitro, upregulated the mRNA expression of two
transmembrane ACs (tmACs) genes, ADCY3 (AC3), and
ADCY9 (AC9), in the ONH astrocytes from AA donors12.
This suggests an intriguing possibility that the activation
of intracellular cAMP signaling pathway may have a role
in the pathogenesis of glaucomatous ONH astrocytes.
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Nevertheless, the precise cellular and molecular mechanism
(s) of the activation of cAMP signaling pathway in astrocyte
dysfunction in glaucomatous ONH degeneration remains to
be determined. These mechanisms may be related to oxi-
dative stress.
Oxidative stress has long been thought to be an impor-
tant pathophysiological mechanism in many neurodegen-
erative diseases including glaucoma2,4,13–15. Astrocytes are
the responsible cell type for many pathological alterations
in the oxidative stress-mediated glaucomatous ONH
degeneration2–4,16. Interestingly, activation of the tmACs-
mediated cAMP/protein kinase A (PKA) signal pathway
induced by forskolin is associated with increased vulner-
ability to hydrogen peroxide (H2O2)-induced oxidative
stress in rat neocortical astrocytes in vitro17. These find-
ings collectively suggest that the elevated intracellular
cAMP-mediated PKA signaling pathway contributed to
oxidative stress-induced dysfunction of astrocytes during
glaucomatous ONH degeneration.
In the present study, we investigate the impact of acti-
vation of cAMP/PKA pathway and its synergistic effect
with oxidative stress on ONH astrocyte dysfunction.
Results
Elevated cAMP impairs ONH astrocytes, but promotes RGC
survival
Intriguingly, our results demonstrated that forskolin
treatment significantly increased intracellular cAMP level
and PKA activity, accompanying by dose-dependent
reduction of cell viability measured by 3-[4, 5-dimethyl-
thiazol-2yl]-2, 5-diphenyl tetrazolium bromide (MTT)
assay (Figs. 1a-d). As it has been reported that AC and
PDE4 (a cAMP-specific PDE) are two key enzymes that
control intracellular cAMP level in RGCs18, we co-treated
RGCs with forskolin and rolipram, a specific inhibitor of
PDE4, to enhance cAMP-mediated PKA activity and with
forskolin and H89 to inhibit cAMP-mediated PKA activ-
ity. The elevated cAMP level was positively correlated
with viability of RGCs (Fig. 1e), whereas PKA inhibition
significantly suppressed cAMP-mediated promotion of
cell viability in cultured RGCs (Fig. 1f).
Elevated cAMP inhibits AKT phosphorylation and induces
caspase-3-mediated cell death in ONH astrocytes
Elevated cAMP significantly decreased the level of AKT
phosphorylation (pAKT) at serine 473 (S473) normalized
by total AKT in ONH astrocytes (Fig. 2a). Using forskolin
together with H89, a PKA inhibitor, or CE3F4, a specific
inhibitor of an exchange protein directly activated by
cAMP (Epac)19, we further addressed that elevated
cAMP-mediated inhibition of AKT phosphorylation was
dependent on the PKA pathway but not Epac pathway
(Figs. 2b and c). Following prolonged elevation of cAMP
levels by forskolin and rolipram (24 h), the polygonal,
fibroblast-like shape of ONH astrocytes were changed to
the extensive stellate-like morphology within a few hours,
most likely to be a reactive astrogliosis and this mor-
phological alteration was sustained for 24 h upon
increasing cAMP level (Supplementary Fig. S1). Notably,
consistent with compromised cell viability in ONH
astrocytes by the rolipram treatment (1 h; Fig. 2d), pro-
longed elevation of cAMP level not only suppressed AKT
phosphorylation but also increased the cleaved caspase-3
protein level in ONH astrocytes (Figs. 2e and f).
Inhibiting cAMP/PKA pathway prevents Bim/Bax pathway
and caspase-3 activation in ONH astrocytes
Quantitative real-time reverse transcription (RT)-poly-
merase chain reaction (PCR) analysis demonstrated that
forskolin treatment induced a substantial increase of Bim
expression in ONH astrocytes among apoptosis-related
genes that are regulated by NF-κB (TNFα, Bcl-2, and Bcl-
xL) or FoxO (Bim, Bcl-6, Puma, Bnip3, Trail, and FasL)
(Fig. 3a). By selecting Bim as an AKT target gene regu-
lated by cAMP, we further observed that PKA inhibition
by H89 significantly suppressed Bim mRNA expression in
forskolin-treated ONH astrocytes (Fig. 3b). Insulin-like
growth factor 1 (IGF-1) regulates apoptosis and oxidative
stress response via phosphatidylinositol-5-bisphosphate
3-kinase (PI3K)/AKT signaling pathway in astrocytes20.
We found that IGF-1 reversed cell viability that was
reduced by forskolin treatment alone in an AKT-FoxO-
dependent manner in ONH astrocytes (Fig. 3c and Sup-
plementary Fig. S2). There was no significant difference in
lactate dehydrogenase (LDH) release between forskolin-
and IGF-1-treated ONH astrocytes (Fig. 3d).
Co-immunoprecipitation (Co-IP) revealed that forskolin
treatment promoted the interaction between Bim and Bcl-
xL in ONH astrocytes (Fig. 3e). In contrast, PKA inhibi-
tion blocked this interaction in forskolin-treated ONH
astrocytes (Fig. 3e). Furthermore, prolonged elevation of
cAMP levels by forskolin and rolipram (24 h) significantly
increased both Bim and activated Bax protein expression
in ONH astrocytes (Fig. 3f). By co-treatment with for-
skolin, Rp diastereomers of cAMP (Rp-cAMP), a PKA
inhibitor, or H89 in cultured ONH astrocytes for 24 h,
inhibition of cAMP/PKA pathway by Rp-cAMP sig-
nificantly decreased activated Bax and cleaved caspase-3
protein expression in ONH astrocytes, whereas the
expression level of pAKT S473 in ONH astrocytes was not
changed compared with the control treated with forskolin
(Fig. 3g). However, interestingly, inhibition of cAMP/PKA
pathway by H89 significantly increased the levels of pAKT
S473, whereas cleaved caspase-3 protein expression was
not decreased and the expression level of Bax in ONH
astrocytes was not changed (Fig. 3g). In addition, con-
sistent with our result of reduction in activated Bax and
caspase-3 protein expression, immunocytochemical
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analysis confirmed that inhibition of cAMP/PKA pathway
by Rp-cAMP decreased immunoreactivities for activated
Bax and caspase-3 protein expression that were increased
in forskolin-treated ONH astrocytes, accompanied by an
extensive stellate-like morphology that is likely to be a
reactive astrogliosis (Supplementary Fig. S3).
Enhanced cAMP levels are correlated with an increase in
activated Bax and caspase-3 expression in glaucomatous
ONH astrocytes
Because glaucomatous DBA/2 J mice, an extensively
characterized strain that spontaneously develops elevated
IOP with aging21, show the structural and functional
abnormalities of ONH astrocytes in glaucoma progres-
sion3,5,6, we used DBA/2 J mice to determine whether
glaucomatous ONH astrocytes alters the expression levels
of cAMP, Bax and caspase-3 protein. Serial block-face
scanning electron microscopy (SBEM) data sets showed
degenerative structural changes in astrocyte processes in
the glial lamina of 10-month-old glaucomatous DBA2/J
mice, accompanied by axon degeneration (Figs. 4a–c).
Further analysis of three-dimensional reconstruction of
segmentations of axon bundle and astrocyte processes in
SBEM stacks revealed a well-organized longitudinal shape
of axon bundle in the glial lamina of DBA/2J-Gpnmb+
mice (Fig. 4d), whereas distorted axon bundles were
prominent in the glial lamina of glaucomatous DBA/2 J
mice (Fig. 4e). On the other hand, astrocytes in the glial
lamina of DBA/2J-Gpnmb+ mice presented an irregular
arrangement of processes, which is likely a shape of hook
and loop (Fig. 4f and Supplementary Movie S1). However,
although a moderate glaucoma damage caused a loosen
arrangement of astrocytic processes (Fig. 4g and Supple-
mentary Movie S2), severe glaucoma damage induced a
significant loss of astrocytic processes in the glial lamina
of glaucomatous DBA/2 J mice (Fig. 4h and Supplemen-
tary Movie S3). Importantly, glaucomatous astrocytes
showed an increase of cAMP, Bax, and caspase-3 immu-
noreactivities (Figs. 5a–c and Supplementary Fig. S4).
Elevated cAMP exacerbates vulnerability to oxidative
stress in ONH astrocyte dysfunction
Of interest, elevated intracellular cAMP by forskolin
exacerbated the reduction of cell viability in oxidative
stress-induced ONH astrocytes by a dose-dependent
manner (Fig. 6a) and enhanced cAMP level by rolipram
significantly decreased cell viability in oxidative stress-
induced ONH astrocytes compared with controls
(Fig. 6b). Furthermore, elevated cAMP significantly
increased cell death in oxidative stress-induced ONH
astrocytes (Fig. 6c). The splicing of the precursor TNFα
mRNA into the mature form is responsive to external
Fig. 1 Effects of elevated intracellular cAMP on ONH astrocytes and RGCs. a Immunocytochemial analysis of GFAP and NCAM immunoreactivity in
purified ONH astrocytes. Scale bar, 20 μm. b Intracellular cAMP level ONH astrocytes treated with forskolin (10 μM) for 1 h. c PKA activity in ONH astrocytes
treated with forskolin (10 μM) for 1 h. d Cell viability analysis using MTT assay in ONH astrocytes treated with forskolin (0–40 μM) for 1 h. e Thy-1 (green)-
positive primary RGCs cultures. Scale bar, 20 μm. f Cell viability assay using MTT in cultured RGCs treated with forskolin (10 μM), rolipram (2 μM), or H89
(10 μM) for 48 h. For each determination, the cAMP level was normalized to the protein contents, and the PKA activity and cell viability in controls was
normalized to a value of 1.0. Data are shown as the mean ± S.D. (n = 3). **P < 0.01; ***P < 0.001 (two-tailed unpaired Student’s t-test)
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stresses22. Quantitative RT-PCR analyses demonstrated
that H2O2 treatment alone induced a significant increase
of the expression level of mature TNFα mRNA in ONH
astrocytes in a dose-dependent manner, in contrast to a
significant decrease in the expression level of precursor
transcripts of TNFα mRNA (Fig. 6d). Interestingly, for-
skolin treatment alone also induced the reciprocal shifts
in the expression levels of precursor and mature TNFα
mRNA in ONH astrocytes by decreasing precursor TNFα
mRNA but by increasing mature TNFα mRNA (Fig. 6e).
More importantly, forskolin treatment in H2O2-treated
ONH astrocytes induced the maximum shift from the
precursor to mature TNFα mRNA level (Fig. 6e).
However, surprisingly, oxidative stress significantly
decreased the intracellular cAMP level and PKA activity
in ONH astrocytes, accompanying by increased ROS
production and reduced cell viability compared with the
controls (Figs. 7a–d). Consistently, immunocytochemistry
analysis confirmed that cAMP immunoreactivity was
decreased in the cytoplasm of oxidative stress-induced
ONH astrocytes (Fig. 7e). Among candidates for the PKA
target genes (nur77, areg, nr4a2, il-6, rgs2, and dusp1),
which are known as specific target genes of the cytosolic
PKA pathway23,24, the expression level of nur77 and
dusp1 mRNA was upregulated by H2O2 treatment alone
but not by H2O2 and forskolin together, while aregmRNA
Fig. 2 Effects of elevated intracellular cAMP on AKT phosphorylation and caspase-3 protein expression in ONH astrocytes. a Immunoblot
analyses of pAKT S473 and total AKT in ONH astrocytes treated with forskolin (10 μM) for 1 h. b Immunoblot analyses of pAKT S473 and total AKT in
ONH astrocytes treated with H89 (10 μM) or CE3F4 (10 μM) for 1 h. c Immunoblot analyses of pAKT S473 and total AKT in ONH astrocytes treated with
CE3F4 (10 μM) and/or forskolin (10 μM) for 1 h. d Cell viability assay in rolipram-treated ONH astrocytes for 1 h. e Immunoblot analysis of pAKT S473
and total AKT in ONH astrocytes co-treated with forskolin (10 μM) and rolipram (2 μM) for 24 h. f Immunoblot analysis of GFAP and caspase-3 in ONH
astrocytes treated with forskolin (10 μM) and rolipram (2 μM) for 24 h. Note that enhanced cAMP level induced caspase-3 mediated cell death in ONH
astrocytes. For each determination, the cell viability as well as the ratio of pAKT/total AKT protein level and other protein expression in controls was
normalized to a value of 1.0. Data are shown as the mean ± S.D. (n = 3). *P < 0.05; **P < 0.01; ***P < 0.001 (two-tailed unpaired Student’s t-test)
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expression was not changed in both H2O2- and forskolin-
treated ONH astrocytes (Supplementary Fig. S5). Real-
time quantitative RT-PCR analysis demonstrated that
forskolin treatment alone significantly upregulated the
expression levels of rgs2, il-6, and nr4a2 mRNA in ONH
astrocytes (Fig. 7f). However, the increased level of these
genes was significantly decreased in ONH astrocytes
co-treated with H2O2 and forskolin (Fig. 7f). In addition,
Fig. 3 Activation of cAMP/PKA pathway induces ONH astrocytes death via Bax and caspase-3 activation. a Real-time RT-PCR analysis of NFκB-
and FoxO-dependent gene expression in ONH astrocytes treated with forskolin (10 μM) for 1 h. Data were normalized by GAPDH expression. b Real-time RT-
PCR analysis of Bim mRNA expression in ONH astrocytes treated with forskolin (10 μM) or forskolin (10 μM) plus H89 (10 μM) for 1 h. Note that PKA
dependent-regulation of Bim mRNA expression. c and d Cell viability and cell death analysis using MTT assay (c) and LDH assay (d) in ONH astrocytes co-
treated with forskolin (10 μM) and IGF-1 (100 nM) for 24 h. e Co-IP analysis of Bim and Bcl-xL interaction in ONH astrocytes treated with forskolin (10 μM),
H89 (10 μM) or forskolin (10 μM) plus H89 (10 μM) for 1 h. f Immunoblot analysis of Bim and activated Bax in ONH astrocytes co-treated with forskolin
(10 μM) and rolipram (2 μM) for 24 h. g Immunoblot analyses of pAKT, AKT, activated Bax and caspase-3 in ONH astrocyte treated with forskolin (10 μM),
Rp-cAMP (50 μM), or H89 (10 μM) for 24 h. For each determination, the mRNA, ratio of pAKT/AKT protein and other protein expression in controls was
normalized to a value of 100% or 1.0. Data are shown as the mean ± S.D. (n = 3). *P < 0.05; **P < 0.01; ***P < 0.001 (two-tailed unpaired Student’s t-test)
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oxidative stress significantly increased the expression level
of pAKT S473 (Fig. 7g) and decreased the expression
levels of Bim mRNA and protein in ONH astrocytes co-
treated with forskolin (Fig. 7h). Our results also showed
that there was no statistically significant difference in the
expression levels of ADCY10 (AC10) mRNA as well as
sAC protein in cytosolic and mitochondrial fractions in
ONH astrocytes treated with H2O2 (Supplementary
Fig. S6).
Inhibition of cAMP/PKA pathway protects ONH astrocytes
against oxidative stress
Using Rp-cAMP or transduction of adeno-associated
virus serotype 2/5 (AAV2/5)-protein kinase inhibitor
(PKI) that block PKA activity, we pretreated Rp-cAMP or
overexpressed PKI in ONH astrocytes. We found that
PKA inhibition by Rp-cAMP or PKI overexpression sig-
nificantly promoted cell viability in ONH astrocytes
against oxidative stress (Figs. 8a and b). In addition, either
H2O2 treatment or PKI overexpression alone significantly
increased the expression level of pAKT S473 in ONH
astrocytes compared with control cells (Fig. 8c). Surpris-
ingly, the pAKT S473 was highest in PKI-expressing ONH
astrocytes treated with H2O2 (Fig. 8c). However, there
were no statistically significant differences in the expres-
sion levels of Bim and Bax proteins (Fig. 8c). Thus, ele-
vated intracellular cAMP is critically involved in ONH
astrocyte dysfunction via PKA activation-mediated AKT/
Bim/Bax pathway, leading to caspase-3 activation and in
turn, exacerbates cell death in oxidative stress (Fig. 8d).
Discussion
In the present study, we observed that cAMP/PKA
pathway inactivated AKT survival pathway in ONH
astrocytes and subsequently this activated FoxO-mediated
Bim/Bax death pathway, leading to caspase-3 activation-
mediated cell death. Notably, elevated cAMP exacerbated
the vulnerability to oxidative stress in ONH astrocytes
through the PKA pathway. Another intriguing finding was
that inhibition of the PKA pathway also protected ONH
astrocytes against oxidative stress. We therefore propose
that the inhibition of cAMP/PKA signaling pathway can be
an important therapeutic target for ameliorating astrocyte
dysfunction in glaucomatous ONH degeneration.
cAMP signaling pathway is critically involved in a
variety of cellular function including cell survival and
death8,9,25,26. However, little is known about the related
pathophysiological mechanism and its significance on the
activated cAMP signaling pathway in dysfunctional glial
cells, including ONH astrocytes, in neurodegeneration.
Among the main downstream effectors of cAMP signal-
ing, PKA and Epac have a similar affinity to cAMP27 and
contribute to cell growth and death8. Recent evidence
showed that activation of cAMP/PKA pathway has a cri-
tical role in the apoptosis in cancer cell lines28 and vas-
cular smooth muscle cells29. In contrast, reduced cAMP
protects cultured rat cortical astrocytes via the activating
AKT pathway30–32. Our results demonstrated that acti-
vation of cAMP/PKA pathway but not the Epac pathway
diminished phosphorylation of AKT S473 in ONH
astrocytes. The enhancement of cAMP/PKA activity
induced caspase-3 activation-mediated cell death in ONH
astrocytes. Taken together, these findings raise the pos-
sibility that inactivation of AKT by activation of cAMP/
PKA pathway may be an important signal pathway in
ONH astrocyte dysfunction.
AKT pathway controls the expression of apoptosis-
related genes through modulating transcription factors
such as NF-κB33,34 and FoxO35,36. Of note, our results
showed that elevated intracellular cAMP induced a sub-
stantial increase of Bim expression, which is regulated by
FoxO3a transcription factor35,37 in ONH astrocytes.
Moreover, this upregulation of Bim expression by elevated
cAMP was suppressed by PKA inhibition or AKT activa-
tion. This provides evidence that the activated cAMP/PKA
pathway is linked to FoxO-mediated Bim activation in
ONH astrocytes. The pro-apoptotic Bcl-2 homology
domain 3-only protein Bim induces apoptosis, primarily
(see figure on previous page)
Fig. 4 Axon degeneration and structural impairment of astrocyte processes in the glial lamina of glaucomatous DBA/2 J mice.
a Representative SBEM micrographs showed normal healthy morphology of astrocytes and axons in the glial lamina of aged matched non-
glaucomatous DBA/2J-Gpnmb+mice. b Representative SBEM micrographs showed abnormal morphology of astrocytes and degenerative axons in
the glial lamina of 10-month-old glaucomatous DBA/2 J mice that have moderate damage. c Representative SBEM micrographs showed
degenerative astrocytes and severe loss of axons in the glial lamina of glaucomatous DBA/2 J mice that has severe damage. Scale bar, 20 nm. d and
e Axonal segmentation from SBEM volumes. Representative 3D reconstruction micrographs showed normal healthy morphology of axons with
various colors in the glial lamina of non-glaucomatous DBA/2J-Gpnmb+mice d. Representative 3D reconstruction micrographs showed abnormal
morphology of axons with various colors in the glial lamina of glaucomatous DBA/2 J mice that have moderate damage e. f–h Astrocyte process
segmentation from SBEM volumes. Representative 3D reconstruction micrographs showed normal healthy morphology of astrocyte processes with
various colors in the glial lamina of non-glaucomatous DBA/2J-Gpnmb+mice f. Note the arrangement of astrocyte processes, which is likely to show a
shape of hook and loop. Representative 3D reconstruction micrographs showed a loosen arrangement of astrocyte processes with various colors in
the glial lamina of glaucomatous DBA/2 J mice that have moderate damage g. Representative 3D reconstruction micrographs showed loss of
astrocyte processes with various colors in the glial lamina of glaucomatous DBA/2 J mice that have severe damage h. Scale bar, 20 μm
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Fig. 5 (See legend on next page.)
Shim et al. Cell Death and Disease  (2018) 9:285 Page 8 of 18
Official journal of the Cell Death Differentiation Association
through its increased binding activity toward multiple pro-
survival Bcl-2-like proteins38, whose dissociations activate
Bax and Bak39. Indeed, we demonstrated that elevated
cAMP promoted a direct interaction between Bim and
Bcl-xL in ONH astrocytes, and this interaction was
blocked by PKA inhibition. As Bax activation leads to
caspase-3 activation in the mitochondria-related intrinsic
apoptosis signaling pathway40, longer stimulation of cAMP
increased activated Bax and caspase-3 in ONH astrocytes.
These findings strongly suggest the possibility that ele-
vated cAMP contributes to cellular dysfunction through
AKT inactivation and Bim/Bax activation, leading to
intrinsic apoptosis signaling pathway, in ONH astrocytes.
We demonstrated that PKA inhibition by Rp-cAMP
significantly inhibited activation of both Bax and caspase-
3, whereas Rp-cAMP could not restore AKT phosphor-
ylation in forskolin-treated ONH astrocytes. Interestingly,
however, PKA inhibition by H89 restored AKT phos-
phorylation, whereas H89 could not prevent activation of
both Bax and caspase-3 activation in forskolin-treated
ONH astrocytes. It is possible that prolonged activation of
PKA might not completely be prevented by Rp-cAMP
because it is a competitive inhibitor of the cAMP-binding
site of PKA regulatory subunits and its effect is likely to be
diminished when endogenous levels of cAMP are extre-
mely high41. This notion is also supported by the effect of
PKI overexpression on pAKT expression under prolonged
PKA activation by forskolin and rolipram treatment for
24 h. Although pAKT expression was increased in PKI-
overexpressing ONH astrocytes compared with control
cells, PKI did not restore the reduction of pAKT expres-
sion. However, interestingly, PKI significantly decreased
Bax activation (Supplementary Fig. S7), showing a similar
pattern of the effect of Rp-cAMP on PKA. As PKI spe-
cifically inhibits PKA activity by binding to the free cat-
alytic subunit, which mimics the function of regulatory
subunit of PKA42, it is also not sufficient to block the
prolonged activation of PKA completely like as Rp-cAMP.
However, H89 inhibits catalytic subunits of PKA directly
to competing with ATP and it could block completely the
prolonged activation of PKA more efficiently than Rp-
cAMP and PKI43. Furthermore, H89 also inhibits non-
specifically other kinases including Rho-associated kinase
in a PKA-independent manner41. Therefore, the phar-
macological drugs that modulate the regulatory subunit of
PKA may be more attractive than the drugs that modulate
catalytic subunit activity for promoting preventive effect.
As increased cAMP is associated with the promotion of
neurotrophic sensitivity in RGC survival44,45, recent evi-
dence suggested that RGC survival and axon growth are
enhanced by the activation of sAC-generated cAMP9,25
but not likely to be tmACs dependent by examining the
effects of tmACs inhibitors or the AC1/AC8 double
knockout mice25. These results suggested that sAC-
generated cAMP has a critical role for RGC survival and
axon growth, whereas tmACs-generated cAMP has a
minor effect on RGC survival and axon growth. Surpris-
ingly, however, our results demonstrated that elevated
cAMP by forskolin treatment showed a beneficial effect by
promoting cell survival in RGCs. In contrast, pharmaco-
logical inhibition of cAMP/PKA activation lowered the
cell viability in RGCs. Based on these results demon-
strated here, it is possible that elevated cAMP has dis-
tinctive roles in the cellular processes of RGC axons and
astrocytes in glaucomatous ONH degeneration. Previous
studies have reported that glaucomatous damage induced
increase of two tmACs, AC3 and AC9, gene expression in
the unstimulated ONH astrocytes from AA donors with
POAG as well as in the elevated hydrostatic pressure-
induced ONH astrocytes from normal AA donors11,12.
Consistently, these results were supported by the obser-
vation of increased expression levels of cAMP, Bax and
caspase-3 protein in the astrocytes of the glial lamina in
glaucomatous DBA/2 J mice, accompanied by structural
loss of astrocytic processes and degenerative axons.
Together, these results suggest another possibility that
elevated cAMP-dependent pathway is an important player
in not only ONH astrocytes but also RGC axons against
glaucomatous insults such as elevated IOP and oxidative
stress. Collectively, our results identify for the first time a
pathological link between cAMP/PKA pathway activation
and AKT/Bim/Bax-mediated intrinsic cell death pathway
in ONH astrocyte dysfunction.
Oxidative stress is considered as a key risk factor in
many neurodegenerative diseases including glau-
coma2,4,13,15. Our results show that elevated cAMP
(see figure on previous page)
Fig. 5 Increased expression of cAMP as well as activated Bax and caspase-3 in astrocytes of the glial lamina in glaucomatous DBA2/J mice.
a and b Immunohistochemical analyses of cAMP (green), activated Bax (yellow), and caspase-3 (green) as well as GFAP (red) immunoreactivity in the
ONH astrocytes in the glial lamina of age-matched non-glaucomatous DBA/2J-Gpnmb+ and 10-month-old glaucomatous DBA/2 J mice. Note that
representative images showed increases of cAMP, activated Bax, and caspase-3 immunoreactivity in astrocytes of the glial lamina in glaucomatous
DBA/2 J mice compared with non-glaucomatous DBA/2J-Gpnmb+. Nuclei were stained with Hoechst 33342. Scale bar, 20 μm. c Quantitative analysis
showed significant increases of cAMP and GFAP, as well as activated Bax and caspase-3 immunoreactivity in glaucomatous DBA/2 J mice. For each
determination, the immunoreactivity in controls was normalized to a value of 1.0. Data are shown as the mean ± S.D. (n = 5). *P < 0.05; ***P < 0.001
(two-tailed unpaired Student’s t-test)
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exacerbated the vulnerability of ONH astrocytes against
oxidative stress. As a well-known molecular biomarker in
POAG46,47, an increase of TNFα expression has been
reported in glial cells of the ONH from patients with
glaucoma48–50, and glial cell-derived TNFα signaling
pathway is associated with oxidative stress and RGC axon
degeneration in glaucomatous ONH48,50,51. In the present
study, our results demonstrated that elevated intracellular
cAMP may not only activate TNFα by inducing the spli-
cing of TNFα mRNA in ONH astrocytes but also accel-
erated TNFα activation by enhancing the splicing of
TNFα mRNA in ONH astrocyte in synergy with oxidative
stress. On the other hand, intriguingly, our results also
demonstrated that oxidative stress alone induced the
reduction of cAMP level and PKA activity in ONH
astrocytes. Therefore, our findings support the notion that
Fig. 6 Elevated intracellular cAMP exacerbates vulnerability to oxidative stress in ONH astrocytes. a Cell viability assay in ONH astrocytes
treated with H2O2 (50 μM) and/or forskolin (10 μM) for 1 h. b Cell viability analysis using MTT assay in ONH astrocytes treated with H2O2 (50 μM) and/
or rolipram (2 μM) for 1 h. c Cell death analysis using LDH assay in ONH astrocytes treated with H2O2 (50 μM) and/or forskolin (10 μM) for 24 h.
d Schematic illustration of rat pre-TNFα mRNA structure for RT-PCR analysis. The primer location was indicated by arrows. RT-PCR analysis of TNF-α
splicing in ONH astrocytes treated with H2O2 (0–100 μM) for 1 h. e RT-PCR analysis of TNF-α splicing in ONH astrocytes treated with H2O2 (50 μM)
and/or forskolin (10 μM) for 1 h. Data were normalized by GAPDH expression. For each determination, the cell viability, cell death and mRNA
expression in controls was normalized to a value of 1.0 or 100%. Data are shown as the mean±S.D. (n = 3). *P < 0.05; **P < 0.01; ***P < 0.001
(two-tailed unpaired Student’s t-test)
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Fig. 7 (See legend on next page.)
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elevated cAMP-mediated enhancement of TNFα activa-
tion could be critical for oxidative stress-mediated ONH
astrocyte dysfunction and RGC axon degeneration in
POAG.
On the other hand, intriguingly, our results also
demonstrated that oxidative stress alone decreased cAMP
level and PKA activity and subsequently activated AKT
pathway in ONH astrocytes. How is this possible? In the
central nervous system, neurons are most vulnerable cells
to oxidative stress due to their low ROS- detoxifying
capacity, therefore its survival is highly dependent on the
capacity of neighboring astrocytes during oxidative stress-
induced neurodegeneration52,53. Emerging evidence sug-
gests that AKT activity is critical for astrocyte resilience to
oxidative stress and enhances the protective effect of
astrocytes against oxidative stress54. Indeed, we observed
that oxidative stress activated AKT pathway in ONH
astrocytes, accompanied by restoration of Bim expression.
Because a rapid and transient increase in relatively lower
concentration of H2O2 (25 µM) promotes the pro-survival
activity in photoreceptor cells against serum deprivation
by increasing AKT phosphorylation55, our results raise a
possibility that a transient induction of oxidative stress
(relatively low concentration of H2O2) in ONH astrocytes
may trigger the reduction of cAMP level and PKA activity
by a rapid and transient activation of AKT survival
pathway, which in turn, it may inhibit Bim activation. In
addition, our results also demonstrated that enhanced
AKT phosphorylation by IGF-1 rescued ONH astrocytes
against elevated cAMP. These results suggest that
increasing AKT phosphorylation may be an important
endogenous compensatory defense mechanism against
oxidative stress, which is mediated by inactivation of
cAMP/PKA signaling pathway, in ONH astrocytes.
Therefore, the dysregulation of the defense system by
elevated cAMP level may accelerate ONH astrocyte dys-
function in oxidative stress.
Recent evidence has demonstrated that inhibition of
PKA pathway by H89 protected hippocampus against Aβ-
induced oxidative stress via increases of glutathione levels
and superoxide dismutase activity56. Furthermore, anti-
apoptotic markers, such as Bcl-xL, pBad, and heat shock
protein 70, are increased in the brain of aged AC5
knockout mouse that shows resistance against oxidative
stress57. Our results indicated that PKA inhibition by
Rp-cAMP treatment promoted cell viability in ONH
astrocytes against oxidative stress. Furthermore, PKI
overexpression protected ONH astrocytes against oxida-
tive stress by enhancing AKT phosphorylation. Taken
together, these results further support the notion that
activation of cAMP/PKA pathway may exacerbate vul-
nerability to oxidative stress in ONH astrocytes and con-
sequently may promote susceptibility to the factors
contributing to progressive axon degeneration in POAG.
In summary, we provide evidence that the cAMP/PKA
signaling pathway is important to the vulnerability of
oxidative stress-induced ONH astrocytes and that inhi-
bition of intracellular cAMP/PKA signaling activation
may protect ONH astrocytes by increasing AKT phos-
phorylation against oxidative stress. These results suggest
that modulating cAMP/PKA signaling pathway has ther-
apeutic potential for glaucoma pathogenesis.
Methods
Animals
Pregnant Sprague–Dawley rats (250–300 g in weight;
Harlan Laboratories) and adult female DBA/2 J and DBA/
2J-Gpnmb+ mice (The Jackson Laboratory) were housed
in covered cages, fed with a standard rodent diet ad
libitum, and kept on a 12 h light/12 h dark cycle. All
procedures concerning animals were in accordance with
the Association for Research in Vision and Ophthalmol-
ogy Statement for the Use of Animals in Ophthalmic
Vision Research and under protocols approved by Insti-
tutional Animal Care and Use Committee at the Uni-
versity of California, San Diego.
Reagents and other materials
Chemicals and other materials were obtained from the
following sources: H2O2, forskolin, Rp-cAMP, and H89
(see figure on previous page)
Fig. 7 Effects of oxidative stress on cAMP/PKA signaling pathway in ONH astrocytes. a ROS production in ONH astrocytes treated with
H2O2 (50 μM) for 1 h. b Cell viability analysis using MTT assay in ONH astrocytes treated with H2O2 (50 μM) for 1 h. c Intracellular cAMP measurement in
ONH astrocytes treated with H2O2 (50 μM) for 1 h. d PKA activity measurement in ONH astrocytes treated with H2O2 (50 μM) for 1 h. For each
determination, the ROS, cell viability, PKA activity and mRNA expression in controls was normalized to a value of 1.0 and the cAMP level was normalized
to the protein contents. e Immunocytochemical analyses of cAMP and GFAP in ONH astrocytes treated with H2O2 (50 μM) for 1 h. Representative images
showed a decrease of cAMP immunoreactivity in H2O2-treated ONH astrocytes. Note that decreased level of cAMP in the cytoplasm of ONH astrocytes
treated with H2O2 (50 μM). Scale bars, 20 µm. f Real-time RT-PCR analysis of PKA target genes in ONH astrocytes treated with H2O2 (50 μM) and/or
forskolin (10 μM) for 1 h. Data were normalized by GAPDH expression. g Immunoblot analyses of pAKT and total AKT in ONH astrocytes treated with
H2O2 (50 μM) and/or forskolin (10 μM) for 1 h. For each determination, the ratio of pAKT/total AKT protein level in control cells with no treatment was
normalized to a value of 1.0. h Real-time RT-PCR and immunoblot analyses of Bim in ONH astrocytes treated with H2O2 (50 μM) and/or forskolin (10 μM)
for 1 h. Data were normalized by GAPDH and Actin expression, respectively. For each determination, the mRNA and protein expression in controls was
normalized to a value of 100% or 1.0. Data are shown as the mean ± S.D. (n = 3). *P < 0.05; **P < 0.01; ***P < 0.001 (two-tailed unpaired Student’s t-test)
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from Sigma; Rolipram from Cayman Chemical; Recom-
binant Rat IGF-1 from Prospec; DMEM/F12 (1:1), MEM
+GlutaMax, 100× penicillin–streptomycin (Pen/Strep)
and fetal bovine serum from Gibco; Superscript II reverse
transcriptase from Invitrogen; RNase inhibitor, dNTP
mixture and oligo (dT) from Promega; PCR master mix,
protein size marker, SuperSignal West Pico and Femto
chemiluminescent substrates from Thermo scientific;
Amersham Hybond-P (PVDF membrane) and ECL Prime
Western Blotting Detection Reagent from GE Healthcare;
Lab-Tek Chambered cover glass from Nunc; CE3F4 from
TOCRIS.
Tissue preparation
Mice were anesthetized with intraperitoneal injection of a
mixture of ketamine (100mg/kg, Ketaset; Fort Dodge Ani-
mal Health) and xylazine (9mg/kg, TranquiVed; VEDCO
Inc.) before cervical dislocation. For immunohistochemistry,
the retinas and ONHs were dissected from the choroids and
fixed for 2 h at 4 °C with 4% paraformaldehyde (Sigma) in
phosphate-buffered saline (PBS, pH 7.4). After several
washes in PBS, the retinas were dehydrated through graded
ethanols and embedded in polyester wax. For immunoblot
analyses, extracted retinas were immediately used.
Primary ONH astrocyte culture
Primary rat ONH astrocytes were prepared as described
previously with minor modifications16. In brief, after
euthanizing with CO2 gas, 10–20 pieces of ONH tissue
were dissected from postnatal day 5 Sprague–Dawley rats
and transferred to a 35-mm petri dish with 2 ml 0.2%
bovine serum albumin (BSA)/Dulbecco’s phosphate-
buffered saline (DPBS). Under a dissecting microscope,
remnant tissues were removed, and the ONH tissue was
identified and dissected using a micro-scissors and sharp
blade. The ONH tissues were minced and transferred to a
Fig. 8 PKA inhibition protects ONH astrocytes against oxidative stress. a Cell viability analyses using MTT assay in H2O2 (50 μM for 1 h)-induced
ONH astrocytes treated with Rp-cAMP (50 μM). b Cell viability analysis using MTT assay in H2O2 (50 μM)-induced ONH astrocytes transduced with
AAV2/5-tdTomato or mCherry-PKI. Representative images showed tdTomato (red) or mCherry-PKI (red) expression in ONH astrocytes. Nuclei (blue)
were stained by Hoechst 33342. Note that PKI overexpression promoted ONH astrocyte survival. Scale bars, 20 μm. c Immunoblot analyses of pAKT,
total AKT, Bim and activated Bax in H2O2 (50 μM for 1 h)-induced ONH astrocytes transduced with AAV2/5-tdTomato or mCherry-PKI. d A hypothetical
model for the role of tmAC activation-mediated cAMP/PKA signaling pathway in ONH astrocytes against glaucomatous insults such as elevated IOP
and oxidative stress. For each determination, the cell viability as well as mRNA and protein expression in controls were normalized to a value of 1.0.
Data are shown as the mean ± S.D. (n = 3). *P < 0.05; **P < 0.01; ***P < 0.001 (two-tailed unpaired Student’s t-test)
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60-mm petri dish and conditioned with growth medium:
MEM+GlutaMax (Gibco) supplemented with 10% fetal
bovine serum, 100 U/ml penicillin and 100 μg/ml strep-
tomycin (Gibco), and incubated at 5% CO2 at 37 °C. After
incubation for 1–2 weeks, the ONH explants were
removed by 70 μm cell strainers (BD Biosciences). The
cells that were grown from the ONH explants were plated
in a 100mm culture dish and cultured until 80% con-
fluence. For further purification of the ONH astrocytes,
the culture dish was shaken for 16 h at room temperature,
followed by growth medium changing with serum-free
medium and the cells were incubated for 24 h at 5% CO2
at 37 °C. After removing non-adherent cells, the adherent
ONH astrocytes were collected, centrifuged and plated on
poly-L-lysine (PLL)-coated culture dishes.
Primary RGC culture system
RGCs from postnatal 3–5 days of Sprague–Dawley rats
were purified by immunopanning as described pre-
viously58,59. In brief, ~15,000 purified cells were seeded on
24-well plates coated first with poly-D-lysine (10 μg/ml;
Sigma) and then with laminin (10 μg/ml; Sigma) in neu-
robasal medium. RGCs were cultured in serum-free
defined growth medium containing BDNF (50 μg/ml;
PeproTech), CNTF (10 μg/ml; Sigma), insulin (5 μg/ml;
Sigma), and forskolin (10 μM; Sigma).
Cell viability assay
Cell viability was measured using MTT according to the
manufacturer’s recommendations (Cell Proliferation Kit1;
Roche Diagnostics). In brief, ONH astrocytes were plated
on a 96-well plate (0.5~1× 104 per well). After 48 h, the
cells were treated with various reagents for 1 h and 10 μl
MTT stock solution was added to each well including the
negative control. The cells were incubated for 4 h in a
humidified atmosphere of a 5% CO2 incubator at 37 °C
and 100 μl of solubilization solution were added to dis-
solve the formazan crystals that remained in the wells.
After incubation for overnight at 5% CO2 at 37 °C, the
absorbance at 560 and 690 nm were measured with a
microplate reader (SpectraMAX; Molecular Devices).
Each set of data was collected from multiple replicate
wells of each experimental group (n= 3).
Cell death assay
Dead and membrane-ruptured cells were quantitatively
measured by LDH release assay. LDH activity in cultured
medium was assessed with Cytotoxicity Detection Kit
(LDH; Sigma) according to the manufacturer’s instruc-
tions. In brief, After ONH astrocytes were treated with
forskolin (10 µM) and/or H2O2 (50 µM) for 24 h, 100 µl
of cell culture medium of each group were mixed with
the 100 µl reaction mixture in a microplate followed
by 30 min incubation at room temperature in dark
environment. The absorbance of the samples was mea-
sured at 490 nm using a microplate leader (SpectraMAX,
Molecular Devices). Two percent triton X-100-treated
samples were used as positive controls. Each set of data
was collected from multiple replicate dishes of each
experimental group (n= 3).
RT-PCR and quantitative real-time RT-PCR
In brief, total RNA was isolated from the cells using the
RNeasy mini kit (Qiagen), according to the manu-
facturer’s protocol. cDNAs were synthesized from total
RNAs with Superscript II reverse transcriptase and oligo
(dT) primers according to the manufacturer’s protocols.
RT-PCR was performed with cDNAs synthesized from
0.1 μg of the total RNA of each cell as a template and
specific primers (Supplementary Table 1). RT-PCR pro-
ducts were electrophoresed on a 2% agarose gel and
visualized by ethidium bromide staining. For the quanti-
fication of the relative mRNA expressions of each group,
real-time PCR was carried out using MX3000P real-time
PCR system (Stratagene) as follows. cDNAs were ampli-
fied using iQ SYBR Green super-mix (Bio-Rad) and the
specific primers for 40 cycles (initial incubation at 50 °C
for 2 min and then at 95 °C for 10min, and 40 cycles (95 °
C for 15 sec, 55 °C for 1 min, and 72 °C for 1 min)). Output
data were obtained as Ct values and the differential
mRNA expression of each gene among samples was cal-
culated using the comparative Ct method. GAPDH
mRNA, an internal control, was amplified along with the
target genes, and the Ct value of GAPDH was used to
normalize the expression of target genes.
Immunohistochemical and immunocytochemical analyses
For immunohistochemistry of tissue section, five sec-
tions (7 μm thickness) per wax block of ONHs from 10-
month-old glaucomatous DBA/2 J and age-matched non-
glaucomatous DBA/2J-Gpnmb+ mice (n= 3 mice/group)
were prepared. Following incubation in 1% BSA/PBS for
1 h at room temperature to prevent nonspecific back-
ground, the sections were incubated with the primary
antibodies for 16 h at 4 °C. The primary antibodies were
mouse monoclonal anti-cAMP antibody (1:500; abcam),
guinea pig polyclonal anti-GFAP antibody (1:500;
Advanced Immuno Chemical, Inc.), and rabbit polyclonal
caspase-3 (1:100; Cell signaling). After several washing,
the sections were incubated with the secondary antibodies
Alexa Fluor 488 dye-conjugated goat anti-mouse IgG
(1:100; Invitrogen) and Cy5-conjugated anti-guinea pig
IgG antibody (1:100; Jackson ImmunoResearch Labora-
tories) for 2 h at 4 °C and were subsequently washed with
PBS. The sections were counterstained with Hoechst
33342 (1 μg/ml; Invitrogen) in PBS. For immunocy-
tochemistry of cultured ONH astrocytes, the cells were
fixed with 4% paraformaldehyde/PBS for overnight at
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4 °C. After blocking nonspecific background with 1%
BSA/PBS for 1 h at room temperature, primary antibodies
were incubated for 16 h at 4 °C. The primary antibodies
were mouse monoclonal anti-cAMP antibody (1:500;
Sigma), mouse monoclonal anti-Bax antibody (6A7; 1:100;
Santa Cruz), and rabbit polyclonal caspase-3 (1:100; Cell
signaling). After several wash steps, the cells were incu-
bated with the secondary antibody, Alexa Fluor 488
dye-conjugated goat anti-mouse IgG antibody (1:100;
Invitrogen) or Alexa Fluor 488 dye-conjugated goat anti-
rabbit IgG antibody (1:100; Invitrogen) for 4 h at 4 °C and
subsequently washed with PBS. The cells were counter-
stained with Hoechst 33342 (1 μg/ml, Life Technologies)
in PBS. Images were acquired with confocal microscopy
(Olympus FluoView1000; Olympus). ImageJ (http://rsb.
info.nih.gov/ij/) was used to measure the fluorescence
intensity in pixels per area in each cAMP, GFAP, Bax, and
caspase-3 images from glaucomatous DBA/2 J and age-
matched control DBA/2J-Gpnmb+ mice. In each antibody
image acquisition, all imaging parameters remain the
same. Mean pixel intensity was measured in this
11,124 square pixel area.
cAMP measurement
Cells (2~5× 105) were washed in ice-cold PBS, har-
vested by centrifugation at 1800 g for 5 min and extracted
with 0.1M HCl. The extracts were centrifuged at 15,000 g
for 3 min and the supernatants were collected. Intracel-
lular cAMP levels in the final supernatants were measured
by using a direct cAMP ELISA kit (Enzo Life Sciences)
according to the manufacturer’s instructions for acetyla-
tion format. Protein concentration of the same samples
was determined by Bradford protein quantification assay.
Data were normalized to the protein amounts.
ROS measurement
The intracellular ROS was measured by using cell per-
meant reagent 2’,7’–dichlorofluorescin diacetate (DCFHDA,
Sigma). In brief, ONH astrocytes were plated on a PLL-
coated six-well plate (2× 104 cell per well) and after 24 h,
cells were exposed to 50 µM of H2O2 for 3 h in serum-free
condition. The cells were added with 200 nM of DCFHDA,
incubated at 37 °C for 20min and then detached with 0.25%
typsin/EDTA. After washing with DPBS, the fluorescence
intensity of the sample was measured immediately using C6
Accuri flow cytometer (BD Biosciences). Each set of data
was collected from multiple replicate dishes of each
experimental group (n= 3).
PKA activity assay
PKA activity in the samples from ONH atrocytes was
measured by using a non-radioactive PKA activity assay kit
(Enzo Life Sciences). In brief, ONH astrocytes (2× 105)
were seeded on PLL-coated 200mm dishes in normal
growth medium for 48 h. The cells were treated with
indicated reagents in serum-free condition for 1 h. Total
cellular proteins were extracted by using lysis buffer
according to the manufacturer’s instruction. PKA
substrate-coated microtiter plate was soaked with kinase
assay dilution buffer for 10min at room temperature. One
hundred nano-gram in 30 µl of cell lysates or PKA stan-
dard (10 ng) were then added, followed by the addition of
ATP to initiate the kinase reaction. After incubation at
30 °C for 90min, the reaction was terminated by removing
the mixture from the plate, and phosphor specific sub-
strate antibody was added to each well and incubated at
room temperature for 60min. The solution was removed
completely and the wells were repeatedly washed. The
peroxidase-conjugated secondary anti-rabbit IgG was then
added to each well and incubated for another 30min at
room temperature. After several washing, the color was
developed with tetramethylbenzidine substrate for 30–60
min and the reaction was stopped by adding acid-stop
solution. The absorbance was measured at 450 nm with a
microplate reader (SpectraMAX; Molecular Devices). The
absorbance was divided by the concentration of total
protein (µg) in each sample, and the data are represented
as relative PKA activity.
Co-IP and immunoblot analyses
For co-IP, the cell lysates were prepared in co-IP lysis
buffer (20 mM Tris-Cl, pH 7.4, 135mM NaCl, 1.5 mM
MgCl2, 1 mM EGTA, 10% glycerol, 1% Triton X-100)
containing complete protease inhibitors (Roche Bio-
chemicals). IP was performed using Protein A/G PLUS-
Agarose Immunoprecipitation Reagent (Santa Cruz
Biotechnology) and a rabbit polyclonal antibody to Bim
(Santa Cruz Biotechnology) according to the manu-
facturer’s instructions. For immunoblot analyses, cells
were harvested and lysed for 30 min on ice with a mod-
ified RIPA lysis buffer (150 mM NaCl, 1 mM EDTA, 1%
NP-40, 0.1% SDS, 1 mM DTT, 0.5% sodium deoxycholate,
and 50mM Tris-Cl, pH 7.6), containing the complete
protease inhibitors. The lysates were centrifuged at
15,000 g for 15min and the protein amounts in the
supernatants were measured by Bradford methods. Pro-
teins (5–10 μg) were separated by SDS/PAGE and elec-
trotransferred to polyvinylidenedifluoride membrane. The
membrane was blocked with 5% non-fat dry milk and
PBS-T (0.1% Tween-20) for 1 h, incubated with primary
antibodies for overnight at 4 °C. Primary antibodies are
rabbit polyclonal anti-AKT antibody (1:5000; Cell Sig-
naling), mouse monoclonal anti-pAKT antibody (S473,
1:2000; Cell Signaling), rabbit polyclonal anti-pFoxO1/3
(T24,T32, 1:1,000; cell signaling), rabbit polyclonal anti-
caspase-3 antibody (1:3000; Cell Signaling), mouse
monoclonal anti-Bax antibody (6A7; 1:1000; Santa Cruz
Biotechnology), rabbit polyclonal anti-Bcl-xL antibody
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(1:2000; Cell Signaling), mouse monoclonal anti-Bcl-xL
antibody (1:1000; Santa Cruz Biotechnology), rabbit
polyclonal anti-Bim antibody (1:1000; Santa Cruz Bio-
technology), and mouse monoclonal anti-Actin antibody
(1:100,000; Millipore), After several washes in PBS-T, the
membranes were incubated with peroxidase-conjugated
goat anti-mouse or rabbit IgG (1:5000; Bio-Rad), and
developed using enhanced chemiluminescence substrate
system. The images were captured and quantified by using
ImageQuant LAS 4000 system (GE Healthcare Bio-Sci-
ence) and the band densities were normalized to the band
densities for actin.
SBEM
ONH tissues were washed with buffer and then placed
into 2% OsO4/1.5% potassium ferrocyanide in either 0.15
M CB containing 2 mM CaCl2. The tissues were left for 2
h at room temperature. After thorough washing in dou-
ble distilled water, the tissues were placed into 0.05%
thiocarbohydrazide for 30 min. The slices were again
washed and then stained with 2% aqueous OsO4 for 1 h.
The tissues were washed and then placed into 2% aqu-
eous uranyl acetate overnight at 4 °C. The tissues were
washed with water at room temperature and then stained
with en bloc lead aspartate for 30 min at 60 °C. The tis-
sues were washed with water and then dehydrated on ice
in 50, 70, 90, 100, 100% ethanol solutions for 10 min at
each step. The tissues were then washed twice in dry
acetone and then placed into 50:50 Durcupan ACM:
acetone overnight. The tissues were transferred to 100%
Durcupan resin overnight. The tissues were then
embedded and left in an oven at 60 °C for 72 h. SBEM
data were collected with a 3View unit (Gatan Inc.)
installed on a Merlin field emission SEM (Carl Zeiss
Microscopy). The ONH volumes were collected in 2.0–2.
4 kV accelerating voltages, with a raster size of 24k× 24k
and pixel dwell time of 0.5–1 μs. The pixel sizes were
4.0–7.3 nm, depending on the raster size and section
thickness was 60–70 nm. Once a volume was collected,
the histograms for the tissues throughout the volume
stack were normalized to correct for drift in image
intensity during acquisition. Digital micrograph files
(.dm4) were normalized using Digital Micrograph and
then converted to MRC format. The stacks were con-
verted to eight bit and volumes were manually traced for
reconstruction and analysis using IMOD software
(http://bio3d.colorado.edu/imod/)60.
In vitro transduction of recombinant AAV2/5 constructs
Recombinant AAV2/5 was prepared by using AAV
Helper-Free System (Agilent Technology) with some
modification. To generate an AAV2/5 capable of expres-
sing mCherry-PKI fusion protein in astrocytes, AAV2/5
rep, and cap plasmid was purchased from Penn Vector
Core (University of Pennsylvania) and pZac2.1
gfaABC1D-tdTomato61 was a gift from Baljit Khakh
(Addgene plasmid # 44332). To construct pZac2.1
gfaABC1D-mCherry–PKI, the cDNA for mCherry-PKI
was amplified from p4mt-mCherry-PKI that was kindly
provided by Dr. Giulietta Di Benedetto62 by using
following primers; Forward 5’-AAGCTTGAATTC
GCCACCATGGTGAGCAAGGGCGAGGAGGA-3’ and
reverse 5’-AAGCTTGCGGCCGCCTATGACTCGGACT
TAGCAG-3’. The tdTomato portion of pZac2.1
gfaABC1D-tdTomato was replaced with mCherry-PKI at
EcoR I and Not I site. After DNA sequence validation,
these plasmids were used for AAV2/5 production. Viruses
were prepared according to manufacturer’s instruction
(AAV Helper-Free System; Agilent Technology) and
purified by a column chromatography using a ViraTrap
AAV purification kit (Biomiga) as described in the man-
ufacturer’s protocol. Viral titers were determined using a
quantitative real-time PCR method. The both AAV2/5
titers were 2.0× 1012 GC/ml and transduction was per-
formed to ONH astrocytes with 400,000 MOI.
Statistical analyses
Data were presented as the mean± S.D. Comparison
experimental conditions was evaluated using the two-
tailed unpaired Student’s t-test with Bonferroni correc-
tion. p< 0.05 was considered to be statistically significant.
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